Jupiter Endovascular
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $60M
Investors
- 3
About Jupiter Endovascular
Based in California, US, and founded in 2024 by Alex Tilson, Jupiter Endovascular, Inc. operates as a medical technology company that focuses on providing catheter-based medicines for surgical accuracy and control. The company's flagship technology, Endoportal Control™, combines surgical precision with the simplicity of catheter interventions. Jupiter Endovascular focuses on pulmonary embolism, a serious cardiovascular condition, and they are actively advancing therapies in this area. In October 2025, Jupiter Endovascular, Inc.
Who invested in Jupiter Endovascular
3 investors across 2 rounds
See all investors in Jupiter Endovascular
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jupiter Endovascular
Who invested in Jupiter Endovascular?
Jupiter Endovascular has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jupiter Endovascular raised?
Jupiter Endovascular has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Jupiter Endovascular last raise money?
Jupiter Endovascular's most recent round on record is a Series B, in Oct 2025.
What does Jupiter Endovascular do?
Based in California, US, and founded in 2024 by Alex Tilson, Jupiter Endovascular, Inc.
Where is Jupiter Endovascular headquartered?
Jupiter Endovascular is headquartered in Menlo Park, US.
Which VCs invest in companies like Jupiter Endovascular?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Jupiter Endovascular's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Jupiter Endovascular? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.